Marshall Wace North America’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$782K Sell
3,221
-16,043
-83% -$3.92M ﹤0.01% 1005
2021
Q2
$3.98M Buy
+19,264
New +$3.93M 0.02% 614
2021
Q1
Sell
-56,417
Closed -$9.28M 1606
2020
Q4
$9.28M Buy
56,417
+2,069
+4% +$303K 0.04% 399
2020
Q3
$6.78M Sell
54,348
-408,599
-88% -$50.6M 0.04% 341
2020
Q2
$44.9M Buy
462,947
+270,795
+141% +$28.2M 0.3% 91
2020
Q1
$17.3M Sell
192,152
-1,457,174
-88% -$189M 0.13% 170
2019
Q4
$244M Buy
1,649,326
+1,646,670
+61,998% +$221M 1.18% 16
2019
Q3
$320K Sell
2,656
-38,229
-94% -$4.94M ﹤0.01% 877
2019
Q2
$5.53M Buy
+40,885
New +$5.17M 0.03% 339

Other funds holding HCA

Marshall Wace North America's HCA Position: Q3 2021 in Review

Marshall Wace North America reduced its HCA Healthcare (HCA) stake by 83% in Q3 2021, selling an estimated $3.92M and leaving 3,221 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Marshall Wace North America first reported a position in HCA in Q2 2019 and has held it in 9 quarters since. The position peaked at $244M in Q4 2019. 886 funds tracked by Wall St. Rank hold HCA as of Q3 2021.

  • Marshall Wace North America held 3,221 shares of HCA Healthcare worth $782K as of Q3 2021.
  • Marshall Wace North America sold 16,043 HCA Healthcare shares in Q3 2021, an estimated $3.92M.
  • HCA Healthcare made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1005 holding.
  • Marshall Wace North America first reported a position in HCA Healthcare in Q2 2019 and has held it in 9 quarters since.
  • Marshall Wace North America's HCA Healthcare position peaked at $244M in Q4 2019.
  • 886 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.